Clint Miller

Publications

• Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cells. Cai Y, Miller CL, Nagel DJ, Jeon KI, Lim S, Gao P, Knight PA, Yan C. Arterioscler Thromb Vasc Biol. 2011; 31 (3): 616-23
• Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart. Miller CL, Cai Y, Oikawa M, Thomas T, Dostmann WR, Zaccolo M, Fujiwara K, Yan C. Basic Res Cardiol. 2011; 106 (6): 1023-39
• Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells. Jeon KI, Jono H, Miller CL, Cai Y, Lim S, Liu X, Gao P, Abe J, Li JD, Yan C. FEBS J. 2010; 277 (24): 5026-39
• Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications. Miller CL, Yan C. J Cardiovasc Transl Res. 2010; 3 (5): 507-15
• Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy. Miller CL, Oikawa M, Cai Y, Wojtovich AP, Nagel DJ, Xu X, Xu H, Florio V, Rybalkin SD, Beavo JA, Chen YF, Li JD, Blaxall BC, Abe J, Yan C. Circ Res. 2009; 105 (10): 956-64
• Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart. Yan C, Miller CL, Abe J. Circ Res. 2007; 100 (4): 489-501